Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 414.82 | 939.00 | 779.25 | 1.2050 | 1.4551 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 653.00 | 779.25 | 0.8380 | 0.6468 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 482.00 | 779.25 | 0.6185 | 0.1794 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 625.00 | 414.82 | 422.00 | 779.25 | 0.5416 | 0.0191 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 414.82 | 888.00 | 779.25 | 1.1396 | 1.3089 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 870.00 | 779.25 | 1.1165 | 1.2575 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 625.00 | 414.82 | 309.00 | 779.25 | 0.3965 | -0.2766 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 625.00 | 414.82 | 908.00 | 779.25 | 1.1652 | 1.3661 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 356.00 | 779.25 | 0.4569 | -0.1547 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 894.00 | 779.25 | 1.1473 | 1.3261 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 625.00 | 414.82 | 700.00 | 779.25 | 0.8983 | 0.7776 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 941.00 | 779.25 | 1.2076 | 1.4608 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 907.00 | 779.25 | 1.1639 | 1.3633 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 625.00 | 414.82 | 671.00 | 779.25 | 0.8611 | 0.6968 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 414.82 | 930.00 | 779.25 | 1.1935 | 1.4292 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 341.00 | 779.25 | 0.4376 | -0.1938 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 414.82 | 257.00 | 779.25 | 0.3298 | -0.4092 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 648.00 | 779.25 | 0.8316 | 0.6329 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 629.00 | 779.25 | 0.8072 | 0.5804 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 625.00 | 414.82 | 569.00 | 779.25 | 0.7302 | 0.4155 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 640.00 | 779.25 | 0.8213 | 0.6108 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 757.00 | 779.25 | 0.9715 | 0.9373 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 477.00 | 779.25 | 0.6121 | 0.1660 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 1024.00 | 779.25 | 1.3141 | 1.7005 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 625.00 | 414.82 | 344.00 | 779.25 | 0.4415 | -0.1860 |